TCRTAlaunos Therapeutics Inc. Common Stock
1.760USD-6.38%Mkt Cap: 4.47M $P/E: —3d ago
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormo…